Conversation

Trader Brian Jones

@MasterBJones

$NVIV not up much but I think down side risk ifs low so I bought it.

1:29 PM · Dec 24, 2020Twitter Web App

Replying to

and

See my nakd call?

Replying to

and

Put a ticket to in with 67, I’ll see if I get in.

Replying to

and

I’m in, but What made you like this one in particular?

Replying to

and

I’m in. Would be nice if your $CLSN gets picked. Been holding for while.

Replying to

and

Watch $INO for today. An independent study finally published $INO phase 1 results in the Lancet, the British equivalent of the New England. The results were excellent. 95% efficacy and 100% immune response in one of the groups. 33% short float. thelancet.com/journals/eclin